Sort
82,697 grants matching “vaccine development”
Enviromental Factors in the Etiology of Autism
$731,064University Of California Davis · P01 · FY2003 · ES
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis
$731,052Gaya K. Amarasinghe · Washington University · R01 · FY2025 · AI
Immunoglobulins Delivered by AVV Vector for the Prevention of SIV Infection
$731,021Ronald C Desrosiers · University Of Miami School Of Medicine · R01 · FY2020 · AI
Immunoglobulins Delivered by AVV Vector for the Prevention of SIV Infection
$731,021Ronald C Desrosiers · University Of Miami School Of Medicine · R01 · FY2017 · AI
Immunoglobulins Delivered by AVV Vector for the Prevention of SIV Infection
$731,021Ronald C Desrosiers · University Of Miami School Of Medicine · R01 · FY2021 · AI
Immunoglobulins Delivered by AVV Vector for the Prevention of SIV Infection
$731,021Ronald C Desrosiers · University Of Miami School Of Medicine · R01 · FY2019 · AI
Immunoglobulins Delivered by AVV Vector for the Prevention of SIV Infection
$731,021Ronald C Desrosiers · University Of Miami School Of Medicine · R01 · FY2018 · AI
Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic fever
$731,002Manuel L Penichet · University Of California Los Angeles · R01 · FY2025 · AI
TASK A82 Cotton Rat Model for the Evaluation of RSV Vaccines and Therapeutics
$730,904Marina Boukhvalova · Bioqual, Inc. · N01 · FY2016 · AI
Dynamic data-driven decision models for infectious disease control
$730,889Alison P Galvani · Yale University · U01 · FY2014 · GM
Genome-Wide Association Study of HIV-1 Host Genetics Among Injection Drug Users
$730,881Eric O Johnson · Research Triangle Institute · R01 · FY2009 · DA
Building the foundations of commensal vaccines
$730,870Michael Andrew Fischbach · Stanford University · R01 · FY2025 · AI
In vivo testing of novel HIV Env vaccine platforms to advance preclinical HIV vaccine development
$730,867Gavin Morrow · International Aids Vaccine Initiative · P01 · FY2018 · AI
Engineered, multispecific antibodies as broad anti-filovirus therapeutics
$730,859Jonathan R. Lai · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Household Transmission of Cryptosporidium
$730,852Poonum S. Korpe · Johns Hopkins University · R01 · FY2023 · AI
The Consequences of Reinfection with M. tuberculosis
$730,762Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Small Molecule Protease Inhibitors against MERS-CoV
$730,761Kyeong-Ok Chang · Kansas State University · R01 · FY2021 · AI
Nab evolution in humans and RMs
$730,750Garnett H Kelsoe · University Of Pennsylvania · P01 · FY2017 · AI
Preclinical Studies of Bunyaviruses
$730,747Brian R. Murphy · Niaid Extramural Activities · Z01 · FY2007 · AI
Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence
$730,564Yuying Liang · University Of Minnesota · R01 · FY2021 · AI
Immune Senescence
$730,486Jorg J Goronzy · Emory University · U19 · FY2018 · AI
The Functional Significance of CTL Escape
$730,434David I Watkins · University Of Wisconsin-Madison · R37 · FY2009 · AI
Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
$730,427Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2013 · AI
Assessment of vaccine/microbicide combination efficacy in the macaque model
$730,385Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2007 · AI
Rochester Roybal Center for Social Ties and Aging Research
$730,370Kathi L Heffner · University Of Rochester · P30 · FY2022 · AG